Catechol

Catechol

SCHEMBL2555536

CC(C)=O.Oc1ccccc1O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.67
ALDH1A1 P00352 5/20 0.67
CA2 P00918 5/20 0.67
HPGD P15428 4/20 0.67
MAPT P10636 4/20 0.67
CA12 O43570 4/20 0.67
CA14 Q9ULX7 4/20 0.67
LMNA P02545 3/20 0.67
SMN1; SMN2 Q16637 3/20 0.67
TDP1 Q9NUW8 3/20 0.67
CA4 P22748 2/20 0.67
HSD17B10 Q99714 2/20 0.67
NPC1 O15118 2/20 0.67
HIF1A Q16665 2/20 0.67
GMNN O75496 1/20 0.67
EGFR P00533 1/20 0.67
FYN P06241 1/20 0.67
POLB P06746 1/20 0.67
CA3 P07451 1/20 0.67
CYP3A4 P08684 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Catechol SCHEMBL10659163 0.90 KDM4E (0.62) KDM4EALDH1A1CA2HPGDMAPT
Catechol SCHEMBL2707627 0.90 CA2 (0.62) KDM4EALDH1A1CA2HPGDMAPT
Catechol SCHEMBL8411371 0.90 CA2 (0.62) KDM4EALDH1A1CA2HPGDMAPT
Catechol SCHEMBL27612050 0.88 MAPT (0.59) KDM4EALDH1A1CA2HPGDMAPT
Catechol SCHEMBL27477125 0.88 CA2 (0.59) KDM4EALDH1A1CA2HPGDMAPT
Catechol SCHEMBL6611011 0.85 KDM4E (0.58) KDM4EALDH1A1CA2HPGDMAPT
Catechol SCHEMBL4622850 0.85 CA2 (0.56) KDM4EALDH1A1CA2HPGDMAPT
Orthocresol SCHEMBL18725587 0.83 TRPA1 (0.50) KDM4EALDH1A1CA2HPGDMAPT
Catechol SCHEMBL8381469 0.83 ALDH1A1 (0.53) KDM4EALDH1A1CA2HPGDMAPT
Catechol SCHEMBL21296992 0.83 KDM4E (0.53) KDM4EALDH1A1CA2HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020191329-A1 ARAMID AMPHIPHILE SELF-ASSEMBLED NANOSTRUCTURES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-09-24 WO disclosed
US-20200298194-A1 ARAMID AMPHIPHILE SELF-ASSEMBLED NANOSTRUCTURES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-09-24 US disclosed
WO-2019178547-A1 BENZOXAZINE POLYMERS AND METHODS OF MAKING AND USING THE SAME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-09-19 WO disclosed
CN-110156582-A A kind of preparation method of high-purity phloretin 苏州禾研生物技术有限公司 2019-08-23 CN disclosed
CN-109939055-A A kind of anti-oxidant cosmetic composition of duration 上海科颜生物科技有限公司 2019-06-28 CN disclosed
CN-106366723-B A kind of waterborne flame retardant adhesive for the type of resistance to burn-through of weaving 嘉兴市新加新化工有限公司 2019-03-05 CN disclosed
CN-105543108-B Purple stain mould QL-9204 and conversion phloridzin prepare the application in phloretin 浙江工业大学 2019-03-05 CN disclosed
CN-109355317-A A method of phloridzin is converted into phloretin 桂林莱茵生物科技股份有限公司 2019-02-19 CN disclosed
CN-109180628-A A kind of preparation method of apiolin 陕西嘉禾生物科技股份有限公司 2019-01-11 CN disclosed
CN-106366723-A Burnthrough-resistant water-based fire retardant glue for spinning 嘉兴市新加新化工有限公司 2017-02-01 CN disclosed
CN-105543108-A Penicillium purpurescens QL-9204 and application for preparing phloretin during phlorizin conversion UNIV ZHEJIANG TECHNOLOGY 2016-05-04 CN disclosed
US-20140148596-A1 Covalent Organic Frameworks and Methods of Making Same CORNELL UNIVERSITY (US) 2014-05-29 US disclosed
WO-2011127301-A2 COVALENT ORGANIC FRAMEWORKS AND METHODS OF MAKING SAME CORNELL UNIVERSITY (US) 2011-10-13 WO disclosed
US-20030134824-A1 Beta-cyclodextrin dimers and phthalocyanines and uses thereof NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2003-07-17 US disclosed
WO-2003052060-A2 BETA-CYCLODEXTRIN DIMERS AND PHTHALOCYANINES AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134824-A1 Beta-cyclodextrin dimers and phthalocyanines and uses thereof CRY2, CRY1, HCCS KDM4E 4432/4885ALDH1A1 2009/4885CA2 94/4885
US-20200298194-A1 ARAMID AMPHIPHILE SELF-ASSEMBLED NANOSTRUCTURES ANXA6, ANXA1, ANXA11 KDM4E 4448/4885ALDH1A1 3690/4885CA2 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.